Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

NCT07396259 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Circulating Tumor Cells (CTCs)
Immunotherapy
PD-L1 Expression
Liquidbiopsies

Sponsor

Chang Gung Memorial Hospital